BP000087-C014: Recombinant Human Interferon-gamma (IFNγ) Protein
Source: E. coli-derived.
The specific activity as determined in a viral resistance assay using VSV-WISH cells was found to be greater than 1.5 x 107 IU/ mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000087-CYT-206: Recombinant Human Interferon-γ (IFNγ) Protein
Source: E. coli-derived.
The specific activity as determined in a viral resistance assay is < 0.05 ug/ml, corresponding to a specific activity of 2.0 x 10,000,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000087-CYT-358: Recombinant Mouse Interferon-γ (IFNγ) Protein
Source: E. coli-derived.
The specific activity as determined by the cytopathic affect inhibition assay with murine NIH 3T3 cells chalenged with EMC virus was < 0.1 ug/ml, corresponding to a specific activity of 10 MU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000087-CYT-359: Recombinant Rat Interferon-Gamma (IFNγ) Protein
Source: E. coli-derived.
The specific activity as determined by the cytopathic affect inhibition assay with murine L929 cells chalenged with EMC virus was < 0.1 ng/ml, corresponding to a specific activity of 10 MU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000087-CYT-402: Recombinant Porcine Interferon-γ (IFNγ) Protein
Source: E. coli-derived.
The ED50 as determined by the amount of interferon that inhibited 50% of the cytopathic effect of vesicular stomatitis virus in MDBK cells was found to be 0.2-0.6 ng/ml corresponding to a Specific Activity of 1.6-5 IU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000087-CYT-478: Recombinant Human Interferon-γ (IFNγ) Protein, His Tag
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000087-GD24: Recombinant Human Interferon-gamma (IFNγ) Protein
Source: E. coli-derived.
The specific activity as determined in a viral resistance assay using VSV-WISH cells was found to be greater than 1.5 x 107 IU/ mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).